Dr. Richard Platt @HarvardPilgrim @DeptPopMed highlights generic switching studies using Sentinel data, conducted by @US_FDA in conjunction with @BrighamResearch Dr. Josh Gagne. More here: https://t.co/6V8vhclKLs #RegSci2019 https://t.co/y5Hov8qYLv
RT @RTI_HealthIT: Your love is my drug! But love isn’t the drug being evaluated in this article by @RTI_Intl Sr. Director Jen Popovic #Heal…
Your love is my drug! But love isn’t the drug being evaluated in this article by @RTI_Intl Sr. Director Jen Popovic #HealthPolicyValentines https://t.co/2kZHjFxYk3
RT @RTI_HealthIT: Take a look at this recently published article co-authored by @RTI_Intl Sr. Director Jen Popovic evaluating drug utilizat…
RT @RTI_HealthIT: Take a look at this recently published article co-authored by @RTI_Intl Sr. Director Jen Popovic evaluating drug utilizat…
Take a look at this recently published article co-authored by @RTI_Intl Sr. Director Jen Popovic evaluating drug utilization and switching patterns within the FDA's Sentinel System https://t.co/9dSGaHrPaf
RT @HealthPolicyDPM: New publication from HPI’s Anita Wagner and colleagues uses a newly developed analytic tool to explain manufacturer-le…
New publication from HPI’s Anita Wagner and colleagues uses a newly developed analytic tool to explain manufacturer-level drug utilization and switching patterns in the @US_FDA Sentinel system using two case studies. See more here, https://t.co/mBkasMdPz7.